AIC
UTHR icon

Aurora Investment Counsel’s United Therapeutics UTHR Stock Holding History

Aurora Investment Counsel’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-858
Closed -$509K – 124
2026
Q1 		$509K Sell
858
-3,696
-81% -$1.84M 0.28% 97
2025
Q4 		$2.22M Sell
4,554
-2,381
-34% -$1.11M 1.17% 38
2025
Q3 		$2.91M Sell
6,935
-199
-3% -$66.9K 1.52% 4
2025
Q2 		$2.05M Buy
7,134
+549
+8% +$164K 1.08% 39
2025
Q1 		$2.03M Buy
+6,585
New +$2.26M 1.13% 37
2019
Q1 		– Sell
-9,704
Closed -$1.06M – 133
2018
Q4 		$1.06M Sell
9,704
-350
-3% -$40.6K 0.58% 101
2018
Q3 		$1.29M Sell
10,054
-122
-1% -$15.1K 0.61% 94
2018
Q2 		$1.15M Sell
10,176
-35
-0.3% -$3.85K 0.56% 97
2018
Q1 		$1.15M Sell
10,211
-360
-3% -$45.7K 0.58% 97
2017
Q4 		$1.56M Buy
+10,571
New +$1.34M 0.78% 76

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Aurora Investment Counsel's UTHR Position: Q2 2026 in Review

Aurora Investment Counsel sold out of United Therapeutics (UTHR) in Q2 2026, closing a stake of 858 shares — an estimated $509K sold.

Aurora Investment Counsel first reported a position in UTHR in Q4 2017 and held it in 10 quarters. The position peaked at $2.91M in Q3 2025. 881 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Aurora Investment Counsel reported no remaining United Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Aurora Investment Counsel sold 858 United Therapeutics shares in Q2 2026, an estimated $509K.
  • Aurora Investment Counsel first reported a position in United Therapeutics in Q4 2017 and held it in 10 quarters.
  • Aurora Investment Counsel's United Therapeutics position peaked at $2.91M in Q3 2025.
  • 881 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Aurora Investment Counsel's 13F filing for Q2 2026, filed 10 Aug 2026.